The first dose is the most likely to produce mild nausea, fatigue, and changes in bowel patterns
Where exactly is the patient centred, solid, qualitative, peer-reviewed research from back when this ridiculously illogical idea originated
Important note: BPC-157 is still considered investigational and is not FDA-approved
Some practitioners use subcutaneous injections of 200 to 300 mcg once or twice daily, injected into abdominal subcutaneous tissue near the area of concern
Mona miao stwierdzi, i BPC-157 w formie stabilnej soli jest nowym prekursorem w leczeniu zaburze ukadu immunologicznego
~ AlphaMD Your doctor orders a PSA test, the result comes back higher than your last one, and suddenly your mind goes to the worst possible place